Kailera Therapeutics (KLRA) stock: insider trades, news & valuation
Strong buyingShare price and insider trades
Kailera Therapeutics insider trading at a glance (Oct 9, 2026): in the past 12 months, 5 insiders bought $327M and 0 sold $0 of KLRA stock on the open market, including a cluster buy that began Apr 20, 2026.
Get emailed when insiders cluster-buy stocks like KLRA
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
KLRA insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | $327M | 5 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 5 Kailera Therapeutics, Inc. insiders reported open-market purchases totaling $327M, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Apr 20, 2026, when 5 insiders bought a combined $327M.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Apr 22SEC | Rtw Investments, Lp10% Owner | Buy | 500,00010,776,820 held (+5%) | $16.00 | $8.0M | -27.4% | — |
| Apr 20SEC | Bcpe Perseus Investor, Lp10% Owner | Buy | 8,398,43826,255,581 held (+47%) | $16.00 | $134M | -27.4% | — |
| Apr 20SEC | Andrew T. KaplanDirector | Buy | 8,398,43826,255,581 held (+47%) | $16.00 | $134M | -27.4% | — |
| Apr 20SEC | Bcls Fund Iv Investments Gp, Llc10% Owner | Buy | 1,562,50022,583,268 held (+7%) | $16.00 | $25.0M | -27.4% | — |
| Apr 20SEC | Adam KoppelDirector | Buy | 1,562,50022,583,268 held (+7%) | $16.00 | $25.0M | -27.4% | — |
Insiders at Kailera Therapeutics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Bcpe Perseus Investor, Lp10% Owner | $134M | — | Apr 20, 2026 | — |
| Andrew T. KaplanDirector | $134M | — | Apr 20, 2026 | — |
| Bcls Fund Iv Investments Gp, Llc10% Owner | $25.0M | — | Apr 20, 2026 | — |
| Adam KoppelDirector | $25.0M | — | Apr 20, 2026 | — |
| Rtw Investments, Lp10% Owner | $8.0M | — | Apr 22, 2026 | — |
KLRA stock: common questions
Are Kailera Therapeutics, Inc. insiders buying KLRA stock?
In the past 12 months, 5 insiders reported open-market purchases of KLRA worth $327M. The latest was 10% Owner Rtw Investments, Lp bought $8.0M of KLRA at $16.00 — first open-market purchase in our records.
Are Kailera Therapeutics, Inc. insiders selling KLRA stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is KLRA's 52-week range?
Over the past year KLRA has traded between $10.00 and $26.00. It last closed at $11.61 on Oct 9, 2026.